One recent study showed that CD1c+ B cell leukemia precursors are efficiently targeted and lysed by CD1c autoreactive T cells, highlighting a role of group 1 CD1-restrcited T cells in anti-tumor immunity (22). This evidence concerns the gene CD1A and neoplasm.